<DOC>
	<DOCNO>NCT00004486</DOCNO>
	<brief_summary>OBJECTIVES : I . Evaluate efficacy fluoxetine social language deficit , global severity compulsive dimension child adolescent autism . II . Assess effectiveness treatment regimen neurocognitive deficit patient population . III . Compare baseline compulsive severity treatment outcome patient .</brief_summary>
	<brief_title>Randomized Study Fluoxetine Children Adolescents With Autism</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , placebo control , crossover study . All patient receive oral placebo daily week 0 . Patients randomize receive either oral fluoxetine oral placebo daily week 1-8 . Patients crossover receive treatment arm week 12-20 . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Meets diagnostic criterion autism Prior/Concurrent Therapy Other : At least 3 month since prior electroconvulsive therapy At least 1 month since prior investigational drug treatment drug know cause major organ toxicity At least 2 week since prior monoamine oxidase inhibitor At least 6 week since prior long act phenothiazine At least 1 week since prior psychotropic drug No prior fluoxetine 20 mg/day 6 week At least 6 week since prior fluoxetine No concurrent use terfenadine ( Seldane ) astemizole ( Hismanal ) No concurrent electroconvulsive therapy psychotropic drug ( unless otherwise permit ) Prior participation another serotonin reuptake inhibitor trial allow Patient Characteristics Hematopoietic : No significant hematopoietic disease Hepatic : No prior concurrent liver disease Renal : No prior concurrent kidney disease Cardiovascular : No significant cardiovascular disease No abnormal EKG Neurological : No prior seizure disorder high risk development seizures No prior cerebrovascular disease No prior brain trauma Other : Not pregnant nursing Negative pregnancy test No unstable major medical illness systemic disease No moderate severe mental retardation motor deficit ( IQ less 50 ) No family history bipolar disorder No prior concurrent mental disorder ( e.g. , schizophrenia , schizoaffective , organic , bipolar disorder ) No significant autoaggressive behavior serious suicidal risk No prior concurrent gastrointestinal condition No unstable endocrine disease ( e.g. , hypo hyperthyroidism ) No prior concurrent malignancy Must able tolerate taper psychoactive medication No history hypersensitivity severe side effect fluoxetine serotonin reuptake inhibitor No history severe personality disorder noncompliance</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2000</verification_date>
	<keyword>autism</keyword>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>